Blood stability testing during method validation [Bioanalytics]

posted by shujak1 – 2010-06-10 16:53 (5859 d 08:27 ago) – Posting: # 5494
Views: 5,686

Dear All,

It is recommended/required to perform the sample collection-process stability (Blood stability testing) during method validation.

The FDA Method Validation guidance states that drug stability should be proven during sample collection and handling, where the drug is still in blood form. Though EMEA draft guideline for validation has also hinted "Sufficient attention should be paid to the stability of the analyte in sampled matrix directly after blood sampling of subjects and further preparation before storage"

So what are your views on this.

Regards,
Shuja


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
152 visitors (0 registered, 152 guests [including 30 identified bots]).
Forum time: 01:21 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5